摘要
目的:探讨新生儿过氧化物酶体增殖物激活受体γ辅助激活因子-1α(PGC-1α)基因Gly482Ser多态性与妊娠期糖尿病(GDM)的关系。方法:选取在我院住院的50例GDM产妇分娩的新生儿作为实验组以及50例正常产妇分娩的新生儿作为对照组,采用聚合酶链反应—限制性片段长度多态性(PCR-RFLP)技术,检测新生儿PGC-1α基因Gly482Ser多态性情况以及该多态性与产妇GDM的关系。结果:(1)实验组与对照组新生儿PGC-1α基因Gly482Ser多态性及等位基因的分布情况比较,差异无统计学意义(P〉0.05)。(2)分娩GG基因型或GA基因型新生儿的产妇患GDM的风险是分娩新生儿为AA基因型的产妇的3.20倍(95%CI=1.172~8.735)。结论:尚不能表明GDM产妇所分娩新生儿的PGC-1α基因Gly482Ser多态性与正常产妇分娩的新生儿有差异,但通过研究发现新生儿的PGC-1α基因型为AA可能是产妇患GDM的保护因素之一。
Objective:To investigate the relationship between the neonatal PGC-1αgene polymorphism and the pregnancy induced gestational diabetes mellitus(GDM).Methods:Fifty newborns of diabetic pregnant women and 50 controls from our hospital were recruited.PG1-1αgene polymorphism was detected by PCRRFLP to define the relationship between the neonatal PGC-1αgene polymorphism and GDM.Results:(1)There is no significant difference of the distribution of GG,GA and AA genotypes between the two groups(P >0.05).(2)It was discovered that mothers with newborns carrying the GG or AG had 3.2-fold higher risk of GDM than those with newborns carrying the AA genotype.Conclusion:There is on significant difference in allele distribution and Gly482 Ser genotype frequency between two groups.However,we discovered that AA genotype could be one of the protective factors of maternal GDM.
出处
《广西医科大学学报》
CAS
2015年第5期737-740,共4页
Journal of Guangxi Medical University
基金
广西医疗卫生重点科研课题资助项目(No.桂卫重2010033)
广西自然科学基金资助项目(No.2011GXNSFA018201)
关键词
PGC-1Α基因
Gly482Ser多态性
妊娠期糖尿病
新生儿
等位基因
peroxisome proliferator-activated receptor-g coactivator-1α
Gly482Ser polymorphism
gesta tional diabetes mellitus
newborn
allele